期刊文献+

S/O/W法制备氟尿嘧啶缓释微球及其体外释药行为考察 被引量:2

Preparation and In Vitro Release Behavior of 5-Fluorouracil Loaded Sustained Release Microspheres by S/O/W Method
原文传递
导出
摘要 目的制备包封率较高的氟尿嘧啶聚己内酯微球并研究不同粒径载药微球的性质。方法采用S/O/W乳化溶剂挥发法,考察了微球制备工艺中药物分散方法与油相溶剂的挥发速度对微球包封率的影响。将微球筛分后考察不同粒径微球的载药量及体外释药行为,并用扫描电子显微镜观察释药前后微球的表面形态。结果采用优化工艺条件,制得平均包封率为69.3%的微球;药物缓释达9d以上,释药前后微球表面形态无明显变化。结论S/O/W乳化溶剂挥发法制备得到包封率较高、具有缓释特性的氟尿嘧啶聚己内酯微球。 OBJECTIVE To prepare 5-fluorouracil loaded polycaprolactone (PCL) microspheres and study the characteristics of microspheres within different sizes. METHODS Microspheres were prepared by a S/O/W emulsion/solvent evaporation method. The effects of dispersing methods and the evaporation rate of organic solvent on entrapment efficiency were investigated. The microspheres with different sizes were characterized by drug loading, surface morphology and in vitro drug release. RESULTS Microspheres with average entrapment efficiency of 69.3% were obtained under optimized condition. It took more than 9 d for the drug to release completely from the microspheres. There was no obvious change in the surface morphology of microspheres after the drug was completely released. CONCLUSION 5-Fluorouracil loaded sustained release polycaprolactone microspheres with high entrapment efficiency were prepared by S/O/W emulsion/solvent evaporation method.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第3期205-208,共4页 Chinese Pharmaceutical Journal
关键词 微球 聚己内酯 氟尿嘧啶 水包油包固 microspheres polycaprolactone 5-fluorouracil S/O/W
  • 相关文献

参考文献13

  • 1尹静波,陈红丹,罗坤,庄秀丽,陈学思,曹田.生物可降解5-氟尿嘧啶载药微球的制备及性能研究[J].高等学校化学学报,2005,26(6):1174-1176. 被引量:17
  • 2SINHAV R, BANSAL K, KAUSHIK R, et al. Poly- ε -caprolactone microspheres and nanospheres: an overview[J]. Int J Pharm, 2004, 278 (1): 1-23.
  • 3ROHNER D, HUTMACHER D W, SEE P, et al. Individually CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone framework for experimental reconstruction of craniofacial defects in the pig[J]. Mund Kiefer Gesichtschir, 2002, 6(3): 162-167.
  • 4JEONG J H, LEE J Y, CHO K W. Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheres[J]. J Controlled Release, 2003, 92 ( 11 ): 249-258.
  • 5BARBATO F, LA ROTONDA M I, MAGLIO G, et al. Biodegradable microspheres of novel segmented poly(ether-ester-amide)s based on poly(ε-caprolactone) for the delivery of bioactive compounds[J].Biomaterials, 2001, 22 (3): 1371-1378.
  • 6ERMIS D, YUKSEL A. Preparation of spray-dried microspheres of indomethacin and examination of the effects of coating on dissolution rates[J]. J Microencapsul, 1999, 16(3): 315-324.
  • 7HITZMAN C J, ELMQUIST W F, WATTENBERG L W, et al. Development of a respirable, sustained release microcarrier for 5-fluorouracil Ⅰ: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles[J]. J Pharm Sci, 2006, 95(5): 1114-1126.
  • 8ALF L, HIROMITSU Y, HIROFUMI T, et al. Microsphere design for the colonic delivery of 5-fluorouracil[J]. J. Control. Release, 2003, 90 (3): 313-322.
  • 9LINA W J, FLANAGAN D R, LINHARDT R J. A novel fabrication of poly(ε-caprolactone) microspheres from blends of poly( ε-caprolactone) and poly(ethylene glycol)s[J]. Polymer, 1999, 40(7): 1731-1735.
  • 10STEPHANE G, NAJIM JABIR AL AWWADI, CAMILLE D, et al. Poly(ε-caprolactone) and Eudragit micropartieles containing fludrocortisone acetate[J]. Int. Jr. Pharm, 2004, 269 (2): 491-508.

二级参考文献12

  • 1张万国,蒋雪涛.利福平聚乳酸微球的制备[J].第二军医大学学报,1996,17(4):395-397. 被引量:8
  • 2Zinutti C., Kedzierewiez F., Hoffman M. et al.. J. Microenc.[J], 1994, 11: 555-563.
  • 3Elvire Fourniera, Catherine Passirani, Nathalie Colin et al.. Eur. J. Pharm Biopharm[J], 2004, 57: 189-197.
  • 4Fu Y. J., Shyu S. S., Su F. H. et al.. Colloids and Surfaces B[J], 2002, 25: 269-279.
  • 5Mogi Takao, Ohtake Naoko, Yoshida Masaru et al.. Colloids and Surfaces B: Biointerfaces[J], 2000, 17(3): 153-165.
  • 6Ruan G., Feng S. S.. Biomaterials[J], 2003, 24: 5037-5044.
  • 7Meng F. T., Ma G. H., Liu Y. D. et al.. Colloids and Surfaces B: Biointerfaces[J], 2004, 33: 177-183.
  • 8Pinedo H. M., Peters G. F.. J. Clin. Oncol.[M], 1988, 6: 1653-1664.
  • 9Hazrati A. M., Deluca P. P.. Proc. Int. Symp. Contr. Rel. Bioact. Mater.[J], 1989, 16: 79-80.
  • 10卓仁禧,王均,毛海泉.聚磷酸酯-聚氨酯药物释放材料的合成[J].高等学校化学学报,1997,18(7):1207-1211. 被引量:12

共引文献16

同被引文献14

  • 1中国药典[S].2010年版.一部.39-40,189,32.
  • 2Mishra K, Dash A P, Dey N. Andrographolide: A novel antimalarial diterpene lactone compound from Andrographis panieulata and its interaction with curcumin and artesunate [J]. J Trop Med, 2011, 2011: 579518, doi: 10.1155/2011/579518.
  • 3Varma A, Padh H, Shrivastava N. Andrographolide: A new plant-derived antineoplastic entity on horizon [J]. Evid Based Complment Altermat Med, 2011, 2011: 815390, doi: 10.1093/ecarrdnep135. Epuh 2011 Feb 10.
  • 4Aromdee C. Modifications of andrographolide to increase some biological activities: A patent review (2006-2011) [J]. Expert Opin Ther Pat, 2012, 22(2): 169-180.
  • 5Ye L, Wang T, Tang L, et al. Poor oral biolavailability of a promising anticancer agent andrographolide is due toextentive metabolism and effiux by P-glycoprotein [J]. J Pharm Sci, 2011, 100(11): 5007-5017.
  • 6Li G Y, Zhong M, Zhou Z D, et al. Formulation optimization of chelerythrine loaded O-carboxymethyl- chitosan microspheres using response surface metho- dology [J]. IntJBiolMacromol, 2011, 49(1): 970-978.
  • 7Tsai Y M, Jan W C, Chien C F, et al. Optimised nano- formulation on the bioavailability of hydrophobic poly- phenol, curcumin, in freely-moving rats [J]. Food Chem, 2011, 127(3): 918-925.
  • 8Hao J F, Fang X S, Zhou Y F, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box- Behnken design [J]. Int J Nanomed, 2011, 6: 683-692.
  • 9Rahman Z, Zidan A S, Habib M J, et al. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design [J]. Int J Pharm, 2010, 389(1/2): 186-194.
  • 10杨静.穿心莲内酯的研究进展[J].中草药,2009,40(7):1168-1170. 被引量:32

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部